EUZ — Eckert & Ziegler SE Share News
0.000.00%
Last trade - 00:00- €770.94m
- €703.00m
- €311.96m
Brief: Eckert & Ziegler Q1 Net Income EUR 8.5 Million
Brief: Eckert & Ziegler Expects FY Sales Of Just Under EUR 265 Mln For 2024
Brief: Eckert & Ziegler FY Net Income EUR 26.3 Million
Brief: Eckert & Ziegler Says 2023 Net Profit For Year Amounted To EUR 26.3 Mln
Brief: Eckert & Ziegler Completes Change Of Legal Form To SE
Brief: Eckert & Ziegler Extends Ga-68 Activities In Japan
Brief: Eckert & Ziegler To Supply Nucleus Radiopharma With Therapeutic Radioisotopes Ac-225 And Lu-177
Brief: Eckert & Ziegler and Full-Life Technologies Sign Actinium-225 Supply Agreement for Next Generation Radiopharmaceuticals
Brief: Eckert & Ziegler, Artbio Announce Partnership For Lead-212 Conjugates
Brief: Eckert & Ziegler Says Pentixapharm Announces First CNS Lymphoma Patient Dosed in Phase I/II PTT101 Study with Yttrium (90Y) Anditixafortide (PentixaTher)
Brief: Eckert & Ziegler Announces Management Reshuffle
Brief: Dongcheng Biochemicals' Unit Signs Cooperation Agreement With Eckert & Ziegler Radiopharma Projekte
Brief: Eckert & Ziegler Establishes Joint Venture With Dc Pharma
Brief: Eckert & Ziegler 9M Sales At EUR 183.9 Mln
Brief: Eckert & Ziegler To Supply Ablaze Pharmaceuticals With Lutetium-177 For Clinical Trials
Brief: Eckert & Ziegler Prepares Split-Off Of Clinical Assets
Brief: Eckert & Ziegler Q3 Profit At 9.4 Million EUR
Brief: Eckert & Ziegler Q3 Profit At EUR 9.4 Mln
Brief: Eckert & Ziegler And Pharmalogic Sign Reservation Agreement